15051632

Source:http://linkedlifedata.com/resource/pubmed/id/15051632

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003015, umls-concept:C0021467, umls-concept:C0021469, umls-concept:C0034693, umls-concept:C0205225, umls-concept:C0264652, umls-concept:C0600520, umls-concept:C0623362, umls-concept:C1280500, umls-concept:C1879547
pubmed:issue	17
pubmed:dateCreated	2004-5-4
pubmed:abstractText	Matrix metalloproteinases (MMPs) are activated in dilated failing hearts, and angiotensin-converting enzyme (ACE) inhibition prevents left ventricular (LV) dilatation. However, it remains unclear whether activation of MMPs precedes or is secondary to LV remodeling, and an effect of ACE inhibition on MMPs is unknown.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0147763
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme..., http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Enalapril, http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 2, http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 9, http://linkedlifedata.com/resource/pubmed/chemical/Protease Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Tissue Inhibitor of...
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1524-4539
pubmed:author	pubmed-author:HoriMasatsuguM, pubmed-author:ManoToshiakiT, pubmed-author:MasuyamaTohruT, pubmed-author:MiwaTakeshiT, pubmed-author:NishikawaNagahiroN, pubmed-author:SakataYasushiY, pubmed-author:YamamotoKazuhiroK, pubmed-author:YoshidaJunichiJ
pubmed:issnType	Electronic
pubmed:day	4
pubmed:volume	109
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2143-9
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:15051632-Angiotensin-Converting Enzyme Inhibitors, pubmed-meshheading:15051632-Animals, pubmed-meshheading:15051632-Antihypertensive Agents, pubmed-meshheading:15051632-Echocardiography, pubmed-meshheading:15051632-Enalapril, pubmed-meshheading:15051632-Enzyme Activation, pubmed-meshheading:15051632-Enzyme Induction, pubmed-meshheading:15051632-Heart Failure, pubmed-meshheading:15051632-Hypertension, pubmed-meshheading:15051632-Male, pubmed-meshheading:15051632-Matrix Metalloproteinase 2, pubmed-meshheading:15051632-Matrix Metalloproteinase 9, pubmed-meshheading:15051632-Protease Inhibitors, pubmed-meshheading:15051632-Pulmonary Edema, pubmed-meshheading:15051632-RNA, Messenger, pubmed-meshheading:15051632-Rats, pubmed-meshheading:15051632-Rats, Inbred Dahl, pubmed-meshheading:15051632-Tissue Inhibitor of Metalloproteinase-2, pubmed-meshheading:15051632-Ventricular Dysfunction, Left, pubmed-meshheading:15051632-Ventricular Remodeling
pubmed:year	2004
pubmed:articleTitle	Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of Angiotensin-converting enzyme inhibitor.
pubmed:affiliation	Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, Suita, Japan.
pubmed:publicationType	Journal Article